VIMPAT
Google image searchProduct monograph
Active ingredient
lacosamide, 10 MG/ML
DIN: 02357666
Dosage form(s): SOLUTION
Route(s) of administration: INTRAVENOUS
Description: 20ML SINGLE USE VIAL
Schedule: Prescription
Company: UCB CANADA INC
Date: 20-SEP-2011
ATC:
- N03 — ANTIEPILEPTICS (ATC, ATC/DDD, )
- N03A — ANTIEPILEPTICS (ATC, ATC/DDD)
- N03AX — Other antiepileptics (ATC, ATC/DDD)
- N03AX18 — LACOSAMIDE (ATC/DDD)
Reference brand drug: Vimpat
